Increased estrogen levels in overweight and obese women have been linked with an increased risk of fibroid development; other possible mechanisms of fibroid development in this population include altered sex hormone metabolism, reduced production of sex-hormone binding globulin, and systemic inflammation due to obesity.37 Here, PLXNA3 is linked to obesity disorder.